US6749864B2
(en)
|
1986-02-13 |
2004-06-15 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
US5433959A
(en)
*
|
1986-02-13 |
1995-07-18 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
GB2189698A
(en)
*
|
1986-04-30 |
1987-11-04 |
Haessle Ab |
Coated omeprazole tablets
|
GB2189699A
(en)
*
|
1986-04-30 |
1987-11-04 |
Haessle Ab |
Coated acid-labile medicaments
|
US5026560A
(en)
*
|
1987-01-29 |
1991-06-25 |
Takeda Chemical Industries, Ltd. |
Spherical granules having core and their production
|
EP0415990A1
(de)
*
|
1988-05-25 |
1991-03-13 |
Byk Gulden Lomberg Chemische Fabrik GmbH |
Neue fluoralkoxyverbindungen
|
DK399389A
(da)
*
|
1988-08-18 |
1990-02-19 |
Takeda Chemical Industries Ltd |
Injicerbare oploesninger
|
GR1002098B
(en)
*
|
1989-06-08 |
1995-12-28 |
Squibb & Sons Inc |
Pharmaceutical composition having good stability
|
FI94339C
(fi)
|
1989-07-21 |
1995-08-25 |
Warner Lambert Co |
Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
|
ZA919510B
(en)
*
|
1990-12-05 |
1992-10-28 |
Smithkline Beecham Corp |
Pharmaceutical compositions
|
IT1250701B
(it)
*
|
1991-07-24 |
1995-04-21 |
Angelini Francesco Ist Ricerca |
Composizione farmaceutica solida per uso orale a base di dapiprazolo
|
HU9203780D0
(en)
*
|
1991-12-12 |
1993-03-29 |
Sandoz Ag |
Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
|
BR9306702A
(pt)
*
|
1992-07-08 |
1998-12-08 |
Monsanto Co |
Benzimidazóis para aliviar úlceras estomacais em suínos
|
AU4513393A
(en)
*
|
1992-07-17 |
1994-02-14 |
Astra Aktiebolag |
Pharmaceutical composition containing antiulcer agent
|
JPH0656665A
(ja)
*
|
1992-08-03 |
1994-03-01 |
Nippon Chemiphar Co Ltd |
イミダゾール誘導体を含有する胃溶性抗潰瘍剤
|
ZA937382B
(en)
*
|
1992-10-06 |
1994-04-29 |
Warner Lambert Co |
Novel composition for peroral therapy of cognitionimpairment and a process therefor
|
CA2150372C
(en)
*
|
1993-01-19 |
2002-08-20 |
Nancy L. Mills |
Stable oral ci-981 formulation and process of preparing same
|
SE9301830D0
(sv)
*
|
1993-05-28 |
1993-05-28 |
Ab Astra |
New compounds
|
US6875872B1
(en)
|
1993-05-28 |
2005-04-05 |
Astrazeneca |
Compounds
|
EP0995447A1
(de)
|
1993-09-09 |
2000-04-26 |
Takeda Chemical Industries, Ltd. |
Formulierung enthaltend einen Antibakteriellen und einen Antiulcus Wirkstoff
|
CA2173506C
(en)
*
|
1993-10-12 |
2006-05-09 |
Tomohisa Matsushita |
Enteric granule-containing tablets
|
TW280770B
(de)
|
1993-10-15 |
1996-07-11 |
Takeda Pharm Industry Co Ltd |
|
US5399356A
(en)
*
|
1994-03-24 |
1995-03-21 |
The Procter & Gamble Company |
Process for making solid dose forms containing bismuth
|
ES2094694B1
(es)
*
|
1995-02-01 |
1997-12-16 |
Esteve Quimica Sa |
Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
|
SE9500478D0
(sv)
*
|
1995-02-09 |
1995-02-09 |
Astra Ab |
New pharmaceutical formulation and process
|
CH687810A5
(de)
*
|
1995-05-24 |
1997-02-28 |
Mepha Ag |
Pelletformulierung mit Omeprazol.
|
US5824339A
(en)
*
|
1995-09-08 |
1998-10-20 |
Takeda Chemical Industries, Ltd |
Effervescent composition and its production
|
ZA9610792B
(en)
*
|
1995-12-22 |
1997-07-09 |
Kowa Co |
Stabilized pharmaceutical composition
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US6645988B2
(en)
*
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
US6489346B1
(en)
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6090419A
(en)
*
|
1996-05-02 |
2000-07-18 |
Mccormick & Company, Inc. |
Salt compositions and method of preparation
|
US8071128B2
(en)
|
1996-06-14 |
2011-12-06 |
Kyowa Hakko Kirin Co., Ltd. |
Intrabuccally rapidly disintegrating tablet and a production method of the tablets
|
US6623759B2
(en)
|
1996-06-28 |
2003-09-23 |
Astrazeneca Ab |
Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
|
CA2204580A1
(en)
*
|
1997-05-06 |
1998-11-06 |
Michel Zoghbi |
Synthesis of pharmaceutically useful pyridine derivatives
|
US6437139B1
(en)
|
1997-05-06 |
2002-08-20 |
Pdi-Research Laboratories, Inc. |
Synthesis of pharmaceutically useful pyridine derivatives
|
SI9700186B
(sl)
|
1997-07-14 |
2006-10-31 |
Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. |
Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
|
ES2137862B1
(es)
*
|
1997-07-31 |
2000-09-16 |
Intexim S A |
Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
|
US6096340A
(en)
*
|
1997-11-14 |
2000-08-01 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
US6174548B1
(en)
|
1998-08-28 |
2001-01-16 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
DK173431B1
(da)
|
1998-03-20 |
2000-10-23 |
Gea Farmaceutisk Fabrik As |
Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs
|
KR100627614B1
(ko)
*
|
1998-04-20 |
2006-09-25 |
에자이 가부시키가이샤 |
안정화된 벤즈이미다졸계 화합물 함유 조성물로 이루어지는 의약제제
|
ATE348601T1
(de)
*
|
1998-05-18 |
2007-01-15 |
Takeda Pharmaceutical |
Im munde zerfallende tablette enthaltend ein benzimidazole
|
ES2347968T3
(es)
|
1998-07-28 |
2010-11-26 |
Takeda Pharmaceutical Company Limited |
Preparacion solida que se disgrega rapidamente.
|
US6733778B1
(en)
|
1999-08-27 |
2004-05-11 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
US20040224989A1
(en)
*
|
1999-01-29 |
2004-11-11 |
Barberich Timothy J. |
S-lansoprazole compositions and methods
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
IL130602A0
(en)
|
1999-06-22 |
2000-06-01 |
Dexcel Ltd |
Stable benzimidazole formulation
|
SE9902386D0
(sv)
*
|
1999-06-22 |
1999-06-22 |
Astra Ab |
New formulation
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US6262085B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6316020B1
(en)
|
1999-08-26 |
2001-11-13 |
Robert R. Whittle |
Pharmaceutical formulations
|
US6780880B1
(en)
|
1999-08-26 |
2004-08-24 |
Robert R. Whittle |
FT-Raman spectroscopic measurement
|
US6312712B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Method of improving bioavailability
|
US6268385B1
(en)
|
1999-08-26 |
2001-07-31 |
Robert R. Whittle |
Dry blend pharmaceutical formulations
|
US6262086B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6369087B1
(en)
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6326384B1
(en)
|
1999-08-26 |
2001-12-04 |
Robert R. Whittle |
Dry blend pharmaceutical unit dosage form
|
US6312723B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
KR100359256B1
(ko)
*
|
1999-10-06 |
2002-11-04 |
한미약품공업 주식회사 |
란소프라졸의 개선된 제조방법
|
WO2001028559A1
(fr)
*
|
1999-10-20 |
2001-04-26 |
Eisai Co., Ltd. |
Procede de stabilisation de composes benzimidazoles
|
AU1545301A
(en)
*
|
1999-11-22 |
2001-06-04 |
Philippe R. Baudier |
Stable acid labile benzimidazole pharmaceutical compositions
|
US20060034937A1
(en)
*
|
1999-11-23 |
2006-02-16 |
Mahesh Patel |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US20030180352A1
(en)
*
|
1999-11-23 |
2003-09-25 |
Patel Mahesh V. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
DE19959419A1
(de)
|
1999-12-09 |
2001-06-21 |
Ratiopharm Gmbh |
Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
US6242003B1
(en)
|
2000-04-13 |
2001-06-05 |
Novartis Ag |
Organic compounds
|
US6544556B1
(en)
*
|
2000-09-11 |
2003-04-08 |
Andrx Corporation |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
|
WO2002026210A2
(en)
*
|
2000-09-29 |
2002-04-04 |
Geneva Pharmaceuticals Inc. |
Proton pump inhibitor formulation
|
KR100430575B1
(ko)
*
|
2001-02-21 |
2004-05-10 |
주식회사 씨트리 |
란소프라졸 및 그 중간체의 제조방법
|
US20060127474A1
(en)
*
|
2001-04-11 |
2006-06-15 |
Oskar Kalb |
Pharmaceutical compositions comprising fluvastatin
|
US6800264B1
(en)
|
2001-04-27 |
2004-10-05 |
United States Aluminate Company |
Process for stabilizing aqueous aluminate and zirconate solutions
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
US9358214B2
(en)
|
2001-10-04 |
2016-06-07 |
Adare Pharmaceuticals, Inc. |
Timed, sustained release systems for propranolol
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
CA2463690C
(en)
|
2001-10-17 |
2011-08-23 |
Takeda Chemical Industries, Ltd. |
Granules containing acid-unstable chemical in large amount
|
US20040006111A1
(en)
*
|
2002-01-25 |
2004-01-08 |
Kenneth Widder |
Transmucosal delivery of proton pump inhibitors
|
KR100464174B1
(ko)
*
|
2002-03-06 |
2005-01-03 |
코오롱유화주식회사 |
설피닐 벤즈이미다졸 유도체의 제조방법
|
IL164221A0
(en)
*
|
2002-04-09 |
2005-12-18 |
Flamel Tech Sa |
Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillim
|
EP1492511B3
(de)
|
2002-04-09 |
2012-05-02 |
Flamel Technologies |
Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
KR100873419B1
(ko)
*
|
2002-06-18 |
2008-12-11 |
페어차일드코리아반도체 주식회사 |
높은 항복 전압, 낮은 온 저항 및 작은 스위칭 손실을갖는 전력용 반도체 소자
|
US20040028737A1
(en)
*
|
2002-08-12 |
2004-02-12 |
Kopran Research Laboratories Limited |
Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same
|
US6909004B2
(en)
*
|
2002-08-21 |
2005-06-21 |
Teva Pharmaceutical Industries Ltd. |
Method for the purification of lansoprazole
|
ES2534713T3
(es)
|
2002-10-16 |
2015-04-27 |
Takeda Pharmaceutical Company Limited |
Preparaciones sólidas estables
|
MY148805A
(en)
*
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
WO2004039728A1
(en)
*
|
2002-10-24 |
2004-05-13 |
United States Aluminate Company |
Process for stabilizing aqueous aluminate and zirconate solutions
|
US8367111B2
(en)
|
2002-12-31 |
2013-02-05 |
Aptalis Pharmatech, Inc. |
Extended release dosage forms of propranolol hydrochloride
|
WO2004066924A2
(en)
*
|
2003-01-24 |
2004-08-12 |
Andrx Labs Llc |
Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
|
JP2006516574A
(ja)
*
|
2003-02-05 |
2006-07-06 |
テバ ファーマシューティカル インダストリーズ リミティド |
ランソプラゾール安定化方法
|
US20040248942A1
(en)
*
|
2003-02-20 |
2004-12-09 |
Bonnie Hepburn |
Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
US20050220870A1
(en)
*
|
2003-02-20 |
2005-10-06 |
Bonnie Hepburn |
Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
EP1617842A1
(de)
*
|
2003-04-22 |
2006-01-25 |
Dr. Reddy's Laboratories Ltd. |
Orale pharmazeutische formulierungen mit säurelabilen wirkstoffen und einem wasserlöslichen derivat, ihre verwendung und das geeignete verfahren für ihre herstellung
|
ES2234393B2
(es)
*
|
2003-04-29 |
2006-09-01 |
Laboratorios Belmac, S.A. |
"formulaciones de pelets de compuestos bencimidazolicos antiulcerosos y labiles al acido".
|
AR045062A1
(es)
*
|
2003-07-18 |
2005-10-12 |
Santarus Inc |
Formulaciones farmaceuticas para inhibir la secrecion de acido y metodos para preparar y utilizarlas
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
TWI337877B
(en)
*
|
2003-07-18 |
2011-03-01 |
Santarus Inc |
Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
|
EP1660052A2
(de)
*
|
2003-09-03 |
2006-05-31 |
Agi Therapeutics Limited |
Protonenpumpenhemmer-formulierungen und verfahren zur herstellung und verwendung dieser formulierungen
|
US20060003002A1
(en)
*
|
2003-11-03 |
2006-01-05 |
Lipocine, Inc. |
Pharmaceutical compositions with synchronized solubilizer release
|
US20070292498A1
(en)
*
|
2003-11-05 |
2007-12-20 |
Warren Hall |
Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
|
US20050249806A1
(en)
*
|
2004-02-10 |
2005-11-10 |
Santarus, Inc. |
Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory drug
|
EP1720527A2
(de)
*
|
2004-03-03 |
2006-11-15 |
Teva Pharmaceutical Industries Ltd |
Stabile pharmazeutische zusammensetzung mit einem säurelabilen arzneimittel
|
EP1721604A4
(de)
*
|
2004-03-04 |
2008-04-30 |
Takeda Pharmaceutical |
Stabiles kapselpräparat
|
AU2005249367A1
(en)
*
|
2004-04-16 |
2005-12-15 |
Santarus, Inc. |
Combination of proton pump inhibitor, buffering agent, and prokinetic agent
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
WO2006009602A2
(en)
|
2004-06-16 |
2006-01-26 |
Tap Pharmaceutical Products, Inc. |
Multiple ppi dosage form
|
US20050281876A1
(en)
|
2004-06-18 |
2005-12-22 |
Shun-Por Li |
Solid dosage form for acid-labile active ingredient
|
US20060024362A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Pawan Seth |
Composition comprising a benzimidazole and process for its manufacture
|
US8747895B2
(en)
|
2004-09-13 |
2014-06-10 |
Aptalis Pharmatech, Inc. |
Orally disintegrating tablets of atomoxetine
|
US9884014B2
(en)
|
2004-10-12 |
2018-02-06 |
Adare Pharmaceuticals, Inc. |
Taste-masked pharmaceutical compositions
|
NZ589750A
(en)
|
2004-10-21 |
2012-07-27 |
Aptalis Pharmatech Inc |
Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
|
US20060105038A1
(en)
*
|
2004-11-12 |
2006-05-18 |
Eurand Pharmaceuticals Limited |
Taste-masked pharmaceutical compositions prepared by coacervation
|
AU2006213439A1
(en)
*
|
2005-01-03 |
2006-08-17 |
Lupin Limited |
Pharmaceutical composition of acid labile substances
|
FR2881957B1
(fr)
|
2005-02-16 |
2008-08-08 |
Solvay |
Comprimes comprenant une substance biologiquement active et un excipient
|
US20060210637A1
(en)
*
|
2005-03-17 |
2006-09-21 |
Qpharma, Llc |
Stable tablet dosage forms of proton pump inhibitors
|
US9040564B2
(en)
*
|
2005-04-28 |
2015-05-26 |
Eisai R&D Management Co., Ltd. |
Stabilized composition
|
US9161918B2
(en)
|
2005-05-02 |
2015-10-20 |
Adare Pharmaceuticals, Inc. |
Timed, pulsatile release systems
|
US20060252831A1
(en)
*
|
2005-05-06 |
2006-11-09 |
Christopher Offen |
Method for the treatment of magnesium and potassium deficiencies
|
US20060252830A1
(en)
*
|
2005-05-06 |
2006-11-09 |
Brandon Stephen F |
Method for the treatment of magnesium and potassium deficiencies
|
FR2885526B1
(fr)
*
|
2005-05-13 |
2007-07-27 |
Flamel Technologies Sa |
Medicament oral a base d'inhibiteur de pompe a protons
|
US20070026071A1
(en)
*
|
2005-07-28 |
2007-02-01 |
Qpharma, Llc |
Magnesium salt proton pump inhibitor dosage forms
|
US7598273B2
(en)
*
|
2005-10-06 |
2009-10-06 |
Auspex Pharmaceuticals, Inc |
Inhibitors of the gastric H+, K+-ATPase with enhanced therapeutic properties
|
WO2007041790A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jon Pty Limited |
Salts of proton pump inhibitors and process for preparing same
|
EP1785135A1
(de)
|
2005-11-10 |
2007-05-16 |
Laboratorios Del Dr. Esteve, S.A. |
Neue Lanzoprazol enthaltende stabilisierte galenische Formulierungen und ihre Herstellung
|
AU2007266574A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Dexcel Pharma Technologies Ltd. |
Multiple unit pharmaceutical formulation
|
EP2023721A2
(de)
*
|
2006-06-05 |
2009-02-18 |
Auspex Pharmaceuticals Inc. |
Herstellung und verwendung substituierter erythromycin-analoge
|
US20090092658A1
(en)
*
|
2007-10-05 |
2009-04-09 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
GB2444593B
(en)
|
2006-10-05 |
2010-06-09 |
Santarus Inc |
Novel formulations for immediate release of proton pump inhibitors and methods of using these formulations
|
US20080103169A1
(en)
|
2006-10-27 |
2008-05-01 |
The Curators Of The University Of Missouri |
Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
|
TR201910825T4
(tr)
|
2006-12-22 |
2019-08-21 |
Ironwood Pharmaceuticals Inc |
Yemek borusu rahatsizliklarini tedavi̇ etmek i̇çi̇n yöntemler ve bi̇leşi̇mler
|
US20080194307A1
(en)
*
|
2007-02-13 |
2008-08-14 |
Jeff Sanger |
Sports-based game of chance
|
CN104069088A
(zh)
*
|
2007-10-12 |
2014-10-01 |
武田制药北美公司 |
与食物摄入无关的治疗胃肠病症的方法
|
EP2213305A4
(de)
*
|
2007-11-27 |
2010-11-17 |
Ohara Pharmaceutical Co Ltd |
Verfahren zur herstellung eines granulierten materials
|
CN101980700A
(zh)
|
2008-02-20 |
2011-02-23 |
密苏里大学董事会 |
包含奥美拉唑和兰索拉唑以及缓冲剂的组合的组合物及其使用方法
|
UY31698A
(es)
|
2008-03-11 |
2009-11-10 |
Takeda Pharmaceutical |
Preparacion solida de desintegracion oral
|
EP2257220B1
(de)
*
|
2008-03-13 |
2017-06-14 |
Liebel-Flarsheim Company LLC |
Fussbetätigte multifunktionssteuerung für bildgebungssystem
|
US20090263475A1
(en)
*
|
2008-04-21 |
2009-10-22 |
Nagaraju Manne |
Dexlansoprazole compositions
|
EP2293782B1
(de)
*
|
2008-05-06 |
2015-08-12 |
Dexcel Pharma Technologies Ltd. |
Stabile benzimidazolformulierung
|
SI22806A
(sl)
*
|
2008-06-23 |
2009-12-31 |
Krka, Tovarna Zdravil, D.D., Novo Mesto |
Nove kristalinične oblike natrijevega rabeprazola
|
KR20110079641A
(ko)
|
2008-09-09 |
2011-07-07 |
아스트라제네카 아베 |
제약 조성물을 이를 필요로 하는 환자에게 전달하는 방법
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
US20110008432A1
(en)
*
|
2009-06-25 |
2011-01-13 |
Pozen Inc. |
Method for Treating a Patient in Need of Aspirin Therapy
|
SG176724A1
(en)
|
2009-06-25 |
2012-01-30 |
Astrazeneca Ab |
Method for treating a patient at risk for developing an nsaid-associated ulcer
|
CA2781286A1
(en)
*
|
2009-11-20 |
2011-05-26 |
Handa Pharmaceuticals, Llc |
Oral formulation for dexlansoprazole
|
NZ600256A
(en)
|
2009-12-02 |
2014-05-30 |
Aptalis Pharma Ltd |
Fexofenadine microcapsules and compositions containing them
|
TW201127375A
(en)
*
|
2010-01-08 |
2011-08-16 |
Eurand Inc |
Taste masked topiramate composition and an orally disintegrating tablet comprising the same
|
US20110189271A1
(en)
*
|
2010-02-02 |
2011-08-04 |
Vishal Lad |
Pharmaceutical formulations of acid-labile drugs
|
WO2012001705A2
(en)
|
2010-06-29 |
2012-01-05 |
Cadila Healthcare Limited |
Pharmaceutical compositions of (r)-lansoprazole
|
US20130156720A1
(en)
|
2010-08-27 |
2013-06-20 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
WO2012141160A1
(ja)
*
|
2011-04-12 |
2012-10-18 |
沢井製薬株式会社 |
ピタバスタチン含有製剤及びその製造方法
|
CA2860231A1
(en)
|
2011-12-28 |
2013-07-04 |
Pozen Inc. |
Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
|
AU2014207680B2
(en)
|
2013-01-15 |
2018-09-06 |
Ironwood Pharmaceuticals, Inc. |
Gastro-retentive sustained-release oral dosage form of a bile acid sequestrant
|
US20170246187A1
(en)
|
2014-08-28 |
2017-08-31 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
US9498485B2
(en)
|
2014-08-28 |
2016-11-22 |
Lipocine Inc. |
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
|
WO2016126625A1
(en)
|
2015-02-03 |
2016-08-11 |
Ironwood Pharmaceuticals, Inc. |
Methods of treating upper gastrointestinal disorders in ppi refractory gerd
|
US20170042806A1
(en)
|
2015-04-29 |
2017-02-16 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
CN104817492B
(zh)
*
|
2015-05-22 |
2018-05-18 |
抚州三和医药化工有限公司 |
兰索拉唑中间体2-羟甲基-3-甲基-4-(2,2,2-三氟乙氧基)吡啶的分离纯化方法
|
US10736855B2
(en)
|
2016-02-25 |
2020-08-11 |
Dexcel Pharma Technologies Ltd. |
Compositions comprising proton pump inhibitors
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
CA3078723A1
(en)
|
2016-11-28 |
2018-05-31 |
Nachiappan Chidambaram |
Oral testosterone undecanoate therapy
|